NEOGAP Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in NEOGAP Therapeutics?

NEOGAP Therapeutics has 5 investors including Sciety And Eurostars.

Q: How much funding has NEOGAP Therapeutics raised to date?

NEOGAP Therapeutics has raised obfuscated.

Overview

NEOGAP Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About NEOGAP Therapeutics

CB Rank

66292

NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.

Founded

obfuscation

Private

Venture - Series Unknown

Stockholm, Stockholms Lan, Sweden

11-50

neogap.se

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Grant

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Hanjing Xie: Chief Medical Officer
Samuel Svensson: CEO

Details

Legal Name

NEOGAP Therapeutics AB.

Also Known As

NEOGAP

Operating Status

Active

Company Type

For Profit

About the Company

NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.

Phone Number

+46 733 54 21 94

Contact Email

Samuel.svensson@neogap.se

Predictions & Insights

Growth Insight

See this Growth Insight

NEOGAP Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

pTTL (personalised Tumour Trained Lymphocytes)

A personalised cell-based immunotherapy that enhances a patient’s T cells to target and attack solid tumours, currently in clinical trials for advanced colorectal cancer.

PIOR®

A software platform that uses DNA sequencing and machine learning to identify tumour-specific mutations (neoantigens) for personalised cancer immunotherapy.

Research & Development

NEOGAP Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NEOGAP Therapeutics	1	obfuscated obfuscation	Sciety	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Sciety	Yes	Venture Round - NEOGAP Therapeutics	Andreas Lindblom
Sciety	Yes	Venture Round - NEOGAP Therapeutics	Andreas Lindblom
Sciety	Yes	Venture Round - NEOGAP Therapeutics	Andreas Lindblom
Sciety	Yes	Venture Round - NEOGAP Therapeutics	Andreas Lindblom
Sciety	Yes	Venture Round - NEOGAP Therapeutics	Andreas Lindblom